Magnetic pulses to the brain may soothe chemo nerve damage
NCT ID NCT03219502
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests if a non-invasive treatment called repetitive transcranial magnetic stimulation (rTMS) can reduce nerve pain caused by oxaliplatin chemotherapy in people with stage I-IV cancer. rTMS uses magnetic pulses on the scalp to change brain activity. The trial includes 56 participants and compares rTMS to a placebo or a wait-list group to see if it improves pain and discomfort.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new drug shield nerves from Chemotherapy's side effects?
- Smartwatch could spot nerve damage before it starts
- Could simple leg exercises restore balance and blood flow after chemotherapy?
- Blood test may one day personalize drug dosing after stem cell transplants
- Could a simple vibrating pad ease chemo nerve damage?
- New imaging agent aims to sharpen cancer detection